Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2005-12-16 STEWART MICHAEL B Sr. VP & Chief Medical Officer Grant or award · Employee Non-qualified Stock Option (right to buy) +120,000 120,000
2004-12-29 STEWART MICHAEL B Sr. VP & Chief Medical Officer Grant or award · Employee Non-qualified Stock Option (right to buy) +55,000 55,000
2003-12-29 STEWART MICHAEL B Sr. VP & Chief Medical Officer Grant or award · Employee Non-qualified Stock Option (right to buy) +80,000 80,000

Page 1 of 1 · 3 trades